Ultrasound Method for Breast Cancer Detection

Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring

Recruiting Observational Study
Breast Carcinoma Breast Neoplasm
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
550 (estimated)
Sponsor
Mayo Clinic · Other
Who this trial is looking for

This trial is looking for women 18 and older with suspicious breast lumps who need a biopsy or have recently had one. It is also looking for women with confirmed breast cancer who are starting specific treatments.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 years old or older and have a suspicious breast mass scheduled for biopsy.
  • I am 18 years old or older and have been diagnosed with breast cancer.
  • I am receiving treatment for breast cancer and have had a baseline MRI or ultrasound.

You may not be able to join if

  • I have breast implants.
  • I have a condition that makes it hard to use an ultrasound.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study evaluates the effectiveness of a breast ultrasound method for the diagnosis of breast cancer. Diagnostic procedures, such as breast ultrasound, may help find and diagnose breast cancer, and may help measure a patient's response to earlier treatment. The purpose of this research is to test the effectiveness of a new investigational breast ultrasound method to detect an abnormality in the…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * AIM 1: Patient volunteers, ages \>= 18 with suspicious breast masses scheduled for breast biopsy, or at least two weeks or more after breast biopsy * AIM 2: Patient volunteers, ages \>= 18 who have biopsy proven breast cancer and are going under neoadjuvant chemotherapy and/or…
Contacts

No contact information available.